Standard Biotools | FLDM - Equity Capital And Reserves


Standard Biotools reported $399.66M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Agilent USD 6.74B 371M Sep/2025
Becton, Dickinson and Co. USD 25.39B 82M Sep/2025
Bio-Rad Laboratories USD 6.74B 391.9M Sep/2025
Bruker USD 2.49B 625.6M Sep/2025
Danaher USD 52.53B 1.46B Dec/2025
Illumina USD 2.38B 123M Sep/2025
Myriad Genetics USD 372.8M 15.3M Sep/2025
Nikon Corporation JPY 653.36B 11.86B Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sony JPY 7.69T 1.97T Sep/2025
Standard Biotools USD 399.66M 24.88M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Waters USD 2.33B 170.88M Sep/2025